SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 2, 2026

HALO

HALOZYME THERAPEUTICS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $624K total
Actionable Insight • Neutral

The insider cluster is dominated by non-cash grants and routine director sales that are immaterial relative to HALO's $9.1B market cap. No C-suite executive sold shares on the open market. The $624K in open-market sales is noise. Monitor the next 10-Q for any fundamental changes, but this cluster provides no actionable trading signal.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$80.78
T+0 close · Jul 2, 2026 · via day close
Latest settled
+38.10%
T+60 · $111.56
Vs SPY
+36.38%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 6 $80.78entry
  2. T+1 · 4mo ago +0.98%α +1.45% · $81.57
  3. T+5 · 4mo ago −5.78%α −5.50% · $76.11
  4. T+20 · 4mo ago +1.84%α +0.99% · $82.27
  5. T+60 · 7w ago +38.10%α +36.38% · $111.56
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two HALO directors sold a combined $624K in open-market sales over a 3-day window, with the bulk ($548K) from Director Krishnan Mahesh following a derivative exercise. The total sales represent ~0.007% of HALO's $9.1B market cap, a trivial amount. The cluster is dominated by non-cash grants/awards to the CFO and EVP, which carry no economic signal. The open-market sales are small relative to company size and are likely routine portfolio diversification.

Key Financial Metrics

Direction
selling
Total Value
$624.0K
Insiders
2

Key Facts

  • Two directors sold a combined $624K in open-market sales over a 3-day window (June 29, July 1, 2026).
  • Total open-market sales represent ~0.007% of HALO's $9.1B market cap, a trivial amount.
  • The cluster is dominated by non-cash grants/awards to the CFO and EVP (208,041 shares at $0), which carry no economic signal.
  • Director Krishnan Mahesh's sale ($548K) followed a derivative exercise, a common pattern for tax diversification, not a bearish signal.
  • Director Connaughton Bernadette sold a small position ($124K), likely routine portfolio management.
  • No C-suite executives made open-market sales; the CFO's transactions were all non-cash grants and awards.

Financial Impact

Total open-market sales of $624K represent ~0.007% of HALO's $9.1B market cap, a trivial amount.

insider ownershipfloat

Risk Factors

  • No material risk identified from this insider activity, the cluster is too small to be informative.
  • Director sales could increase if the stock continues to appreciate, but current levels are trivial.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
69% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-HALO-1783059252185

Track record

15 reports on HALO

Performance horizon

1 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.70% at T+20 after the Oct 15, 2026 report. 4 of 6 went positive at some point.

Filters
  1. Nov 9, 20268d ago PTAB Trial Bearish 6/10 Entry $102.98 Now $96.50 +6.29% settles Nov 17
  2. Nov 6, 202610d ago Press Release Bullish 6/10 Entry $103.63 to $100.27 Now $96.50 −6.88% ▼ −3.24% −5.84% vs SPY
  3. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $103.63 to $100.27 Now $96.50 −6.88% ▼ −3.24% −5.84% vs SPY
  4. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $124.54 to $131.18 Now $96.50 −22.51% ▲ +5.33% +4.62% vs SPY
  5. Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $124.83 to $128.50 Now $96.50 −22.69% ▲ +2.94% +3.38% vs SPY
  6. Oct 15, 20264w ago PTAB Trial Bearish 7/10 Entry $121.84 to $125.63 Now $96.50 +20.80% ▼ −3.11% −3.54% vs SPY
  7. Oct 15, 20264w ago PTAB Trial Bearish 7/10 Entry $121.84 to $125.63 Now $96.50 +20.80% ▼ −3.11% −3.54% vs SPY
  8. Sep 18, 20268w ago 8-K Mixed 6/10 Entry $112.45 to $113.90 Now $96.50 −14.18% ▲ +1.29% +0.02% vs SPY
  9. Sep 17, 20268w ago Insider Cluster Neutral 2/10 Entry $112.45 to $113.90 Now $96.50 −14.18% ▲ +1.29% +0.02% vs SPY
  10. Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $106.12 to $106.92 Now $96.50 −9.07% ▲ +0.75% −0.36% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens in 7h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026